Fundus Cameras Market Size & Share 2025 - 2034

Fundus Cameras Market Size

The global fundus cameras market was valued at USD 515.2 million in 2024. The market is expected to reach from USD 540.5 million in 2025 to USD 854.8 million in 2034, growing at a CAGR of 5.2% from 2025 to 2034, according to the latest report published by Global Market Insights Inc. The high market growth is attributed to the rising prevalence of eye disorders, technological advancements in imaging devices, increasing government and NGO initiatives in eye care, and growing geriatric population, among other contributing factors.

Fundus cameras are specialized ophthalmic imaging devices used to capture detailed photographs of the interior surface of the eye, including the retina, macula, and optic disc. They assist in diagnosing, monitoring, and managing various eye disorders such as diabetic retinopathy, glaucoma, and macular degeneration.
 

Leading players in the fundus cameras market include Canon, ZEISS, NIDEK, TOPCON, and Nikon (Optos). These companies maintain their competitive edge through continuous product innovation, global market presence, and significant investments in research and development.
 

The market has increased from USD 458.3 million in 2021 and reached USD 498.1 million in 2023, with the historic growth rate of 4.5%. The market growth was driven by the rising prevalence of diabetic retinopathy and glaucoma, coupled with growing adoption of advanced imaging technologies for early disease detection and teleophthalmology integration.
 

The rising prevalence of diabetes, hypertension, and age-related eye conditions, including diabetic retinopathy, glaucoma, and macular degeneration, drives the demand for fundus cameras. For instance, according to the International Diabetes Federation (IDF), approximately 537 million adults aged 20-79 years were living with diabetes in 2021, projected to reach 643 million by 2024. The World Health Organization reported that in 2022, around 1.28 billion adults aged 30-79 years had hypertension globally.
 

Additionally, the National Eye Institute estimates that approximately 3 million Americans were glaucoma patients in 2023, and about 2.1 million adults had age-related macular degeneration. Certainly, timely fundus imaging is important to preserving vision and is considered one of the most important first-line imaging instruments in ophthalmology. The global increase in chronic diseases associated with vision impairment further strengthens this demand.
 

Furthermore, telemedicine adoption has accelerated post-COVID-19, enabling remote eye screenings and monitoring. Fundus cameras integrated with digital platforms allow ophthalmologists to screen patients in rural and underserved areas without in-person visits. This expansion increases patient reach, early disease detection, and healthcare equity, directly boosting market growth.
 

Fundus Cameras Market Trends

The fundus cameras market is growing considerably with the shift toward portable and handheld fundus cameras, integration of artificial intelligence (AI) in healthcare and retinal imaging, growing adoption of non-mydriatic and hybrid fundus cameras, and rising focus on preventive eye care and screening programs, among other factors collectively driving industry growth.
 

• There is a growing demand for compact, lightweight, and user-friendly fundus cameras, especially in primary care and remote settings. Portable models make screening more accessible outside specialized ophthalmology clinics. This trend is particularly strong in emerging economies where affordability and mobility are critical.
   
• Non-mydriatic fundus cameras are more widely accepted because they do not require pupil dilation, which increases patient comfort and reduces imaging time. According to the Centers for Medicare & Medicaid Services (CMS), reimbursements for non-mydriatic fundus photography increased by 23% between 2021 and 2023.
   
• The integration of optical coherence tomography (OCT) with fundus imaging systems provides comprehensive retinal assessment capabilities in a single examination, enhancing diagnostic efficiency. The American Academy of Ophthalmology reported that hybrid OCT-fundus imaging systems usage in clinical settings grew by 35% from 2021 to 2023, with an estimated 42% of ophthalmology practices adopting these systems by 2024.
   
• Additionally, global healthcare systems are emphasizing early detection of eye diseases to prevent irreversible blindness. National health programs and NGOs are increasingly incorporating fundus imaging into regular health check-ups. This preventive focus is driving higher adoption of fundus cameras in both developed and developing regions.
   

Fundus Cameras Market Analysis

Based on the product, the fundus cameras market is segmented into mydriatic fundus cameras, non-mydriatic fundus cameras, and hybrid fundus cameras. The non-mydriatic fundus cameras segment has asserted its dominance in the market by securing a significant market share of 52.8% in 2024 owing to growing demand for quick, patient-friendly retinal imaging without pupil dilation and their rising adoption in primary care and teleophthalmology for large-scale eye disease screening. The segment is expected to exceed USD 430.9 million by 2034, growing at a CAGR of 4.7% during the forecast period.
 

On the other hand, the hybrid fundus cameras segment is expected to grow with a CAGR of 6.2%. The growth of this segment is driven by the rising need for comprehensive retinal assessment in a single exam, combining fundus photography with OCT, which enhances diagnostic efficiency and clinical workflow.
 

• The non-mydriatic fundus cameras segment continues to dominate the market. Non-mydriatic fundus cameras have eliminated the need to dilate the pupil, thereby alleviating the discomfort, waiting, and light sensitivity associated with pupil dilation. This is especially true in the case of the primary screening. This has drastically improved patient compliance in ophthalmic and primary care settings.
   
• Further, the increasing prevalence of diabetes and glaucoma worldwide has created significant demand for efficient screening solutions. According to the International Diabetes Federation (IDF), approximately 537 million adults aged 20-79 years were living with diabetes in 2021, projected to reach 643 million by 2024. The World Health Organization reported that glaucoma affected 80 million people globally in 2022. Non-mydriatic fundus cameras meet this screening need through rapid imaging capabilities and simple operation protocols.
   
• In 2023, the UK National Health Service allocated USD 27 million for diabetic retinopathy screening programs, while India's National Programme for Control of Blindness implemented fundus camera-based screening across 350 districts. Government initiatives and NGO programs focused on blindness prevention are driving the wider adoption of these devices in screening programs.
   
• The mydriatic fundus cameras segment held a revenue of USD 52.1 million in 2024, with projections indicating a steady expansion at 4% CAGR from 2025 to 2034. Owing to their ability to deliver high-resolution, wide-field retinal images essential for detecting subtle pathologies. They are particularly valuable in advanced disease management where detailed visualization beyond the central retina is required. Moreover, their established use in specialized ophthalmology centers sustains consistent demand despite the rise of non-mydriatic alternatives.
   
• The hybrid fundus cameras segment held a revenue of USD 191.1 million in 2024, with projections indicating a steady expansion at 6.2% CAGR from 2025 to 2034. The increasing use of hybrid fundus cameras can be attributed to their ability to convert fundus photography to OCT, allowing the assessment of retina structure in a single session. This dual improvement in functionality allows for higher accuracy in determining diabetic retinopathy and macular degeneration. Growing clinical adoption is further fueled by efficiency gains, reduced patient visits, and increasing demand for advanced multimodal imaging systems.
   

Learn more about the key segments shaping this market

Download Free PDF

Based on end use, the fundus cameras market is classified into ophthalmology clinics, hospitals, and other end users. The ophthalmology clinics segment dominated the market with a revenue share of 59.6% in 2024 and is expected to reach USD 512.9 million within the forecast period.
 

• Ophthalmology clinics are the primary point of care for patients with diabetic retinopathy, glaucoma, and macular degeneration. The growing global burden of chronic and age-related eye diseases is driving higher patient visits. This rising demand strengthens the need for advanced fundus cameras in clinics to support early diagnosis and treatment.
   
• Moreover, these clinics are early adopters of technological innovations such as hybrid fundus cameras (combining OCT and fundus imaging) and AI-assisted diagnostic tools. These advanced systems allow comprehensive retinal assessments in a single visit. The integration of cutting-edge technology strengthens their diagnostic and treatment capabilities.
   
• The hospitals segment held a revenue of USD 157.6 million in 2024, with projections indicating a steady expansion at 4.8% CAGR from 2025 to 2034. Hospitals drive strong demand for fundus cameras as they serve as primary centers for advanced eye disease diagnosis and treatment. The growing patient inflow for diabetic retinopathy, glaucoma, and age-related macular degeneration increases the need for in-house imaging solutions.
   
• Hospitals also benefit from higher budgets and access to reimbursement programs, enabling them to invest in advanced fundus imaging systems. Furthermore, integration of fundus cameras into multidisciplinary care supports comprehensive patient management and better clinical outcomes.
   

North America Fundus Cameras Market
 

North America dominated the global market with the highest market share of 41.6% in 2024.
 

• The U.S. fundus cameras market was valued at USD 182.5 million and USD 189.2 million in 2021 and 2022, respectively. The market size reached USD 201.4 million in 2024, growing from USD 195.9 million in 2023, and is anticipated to grow at a CAGR of 4.5% between 2025 to 2034.
   
• North America has one of the highest diabetes prevalence rates globally, with the CDC reporting that 37.3 million Americans (11.3% of the population) had diabetes in 2022. According to the National Eye Institute, approximately 7.7 million Americans were affected by diabetic retinopathy in 2023, representing a 25% increase from 2021.
   
• According to the American Academy of Ophthalmology, the population of patients who need to get screened for retinas on a regular basis has resulted in an increase in the use of fundus cameras of 15% a year from 2021 to 2023. This makes the region a prime area for diagnostic equipment for retinas. American Medicare has also reported an increase in the number of retinal screenings done from 2021 to 2024 by 30%.
   
• Well-established healthcare facilities, combined with favorable reimbursement frameworks for ophthalmic diagnostic procedures, support the adoption of fundus cameras. Insurance coverage and government-backed healthcare programs encourage patients to undergo preventive screenings. This financial support accelerates device penetration in hospitals and clinics.
   
• Further, the region is at the forefront of adopting cutting-edge ophthalmic technologies, including AI-integrated fundus cameras, non-mydriatic models, and hybrid OCT-fundus systems. Clinics and hospitals in the U.S. and Canada actively invest in innovative devices to improve diagnostic accuracy. This innovation-driven ecosystem fuels steady market growth.
  
   

Europe Fundus Cameras Market
 

Europe fundus cameras market accounted for USD 155.6 million in 2024 and is anticipated to show lucrative growth over the forecast period.
 

• European countries have well-organized national health systems that focus on early detection and treatment of eye illnesses. Remarkably, governmental programs have made retinal imaging part of basic care. This emphasis on early detection and treatment creates a persistent demand for fundus cameras.
   
• Europe has a well-developed infrastructure for medical research and provides significant funding for research and clinical trials in ophthalmology. In 2023, the European Union funded Horizon Europe with USD 111.9 billion, out of which about USD 9.6 billion is earmarked for health research, ophthalmology included. The European Vision Institute indicated that over 450 clinical trials of ophthalmology were ongoing in European research institutions by the year 2022.
   
• Moreover, academic and research institutes have gained access to a wider range of imaging equipment and have adopted fundus cameras for routine retinal imaging and monitoring as well. According to EuroStat, the acquisition of imaging equipment in research institutes in Europe increased by 23% from 2021 to 2023, showing the increased demand for fundus cameras in clinical and research settings that, in turn, has contributed to the economic development of the region.
  
   

Asia Pacific Fundus Cameras Market
 

The Asia Pacific fundus cameras market is anticipated to grow at the highest CAGR of 6.4% during the analysis timeframe.
 

• Asia Pacific has the largest diabetic population in the world, with particular focus in China and India, which also subsequently increases the number of cases of diabetic retinopathy, which need regular retinal screenings. These patients, coupled with the diabetes epidemic, have created significant increases in demand for fundus cameras in both urban hospitals and rural screening programs.
   
• Governments in the region are investing heavily in strengthening healthcare systems, including ophthalmology services. Expansion of eye hospitals, diagnostic centers, and community health clinics is creating a strong foundation for fundus camera adoption. These investments are especially targeted at improving rural and semi-urban access to eye care.
   
• Moreover, cost sensitivity in the region is driving demand for portable and handheld fundus cameras that offer affordability without compromising diagnostic quality. Local manufacturers are also entering the market with competitively priced devices. This affordability factor supports wider penetration across resource-limited settings.
  
   

Latin America Fundus Cameras Market
 

The Latin America fundus cameras market is experiencing robust growth over the analysis timeframe.
 

• Latin America is experiencing a steady rise in cases of preventable blindness due to inadequate early diagnosis, creating strong demand for fundus cameras. Limited access to specialized ophthalmologists in rural regions drives reliance on diagnostic devices for quicker detection.
   
• Economic growth in countries like Brazil, Mexico, and Chile is enabling greater healthcare spending, including investments in advanced imaging. Increasing penetration of private eye care clinics is boosting demand for high-quality fundus imaging systems.
   
• There is growing support for the purpose of eye screening for the poorer sections of the population from NGOs and global support initiatives. Alongside the growing practice of ophthalmic medicine in the region, the increasing global demand has led to the increasing use of modern diagnostic technology. There are also innovative strategies, such as public-private partnerships aimed at improving access to fundus cameras.
  
   

Middle East and Africa Fundus Cameras Market
 

The Middle East and Africa market is experiencing robust growth over the analysis timeframe.
 

• The MEA region faces a high prevalence of cataracts, glaucoma, and uncorrected refractive errors, fueling the need for advanced retinal diagnostics. Rapid urbanization and lifestyle changes are increasing cases of diabetes, making diabetic retinopathy screening a priority.
   
• Governments in the Gulf states are heavily investing in modern healthcare infrastructure, including ophthalmology departments. International organizations such as the WHO and IAPB are running eye health programs, encouraging adoption of fundus cameras in public health campaigns. Rising awareness about preventive eye care is gradually shifting focus from treatment to early detection.
   
• Private sector growth, especially in specialized eye hospitals in countries like the UAE and Saudi Arabia, is supporting higher adoption of premium imaging devices. Additionally, partnerships with global medical device companies are improving training, technology transfer, and access to advanced fundus imaging solutions.
   

Fundus Cameras Market Share

The global fundus cameras market is characterized by a mix of established global players and emerging companies focusing on niche innovations. Major manufacturers emphasize product differentiation through advanced technologies such as non-mydriatic imaging, hybrid OCT-fundus systems, and portable solutions to address growing demand across diverse care settings.
 

Key players include Canon, ZEISS, NIDEK, TOPCON, REVENIO, and Nikon (Optos), collectively accounting for 62.7% of the total market share. Their strong distribution networks, brand reputation, and continuous research and development investments give them a dominant edge in the global market.
 

In contrast, smaller and regional players are increasingly competing by offering cost-effective and user-friendly devices tailored for local markets, especially in emerging economies.
 

Strategic collaborations, partnerships with teleophthalmology providers, and integration of AI-based retinal screening are helping these companies gain traction. As competition intensifies, innovation, affordability, and digital integration are expected to be the key differentiating factors shaping the market’s future dynamics.
 

Fundus Cameras Market Companies

Few of the prominent players operating in the fundus cameras industry include:

• Canon
• epipole
• Forus Health
• Huvitz
• Kowa
• NIDEK
• Nikon (Optos)
• OPTOMED
• Remidio
• REVENIO
• SAMSUNG
• TOPCON
• Visionix
• Volk Optical
• ZEISS
  
   
• ZEISS

ZEISS, leading the fundus cameras market with a 17.5% share in 2024, differentiates itself through premium-quality imaging systems known for exceptional clarity and integration with digital platforms. Its continuous research and development in multimodal imaging solutions, including widefield and OCT-fundus combinations, positions it as a leading innovator in advanced ophthalmic diagnostics.

• Canon

Canon stands out for its high-precision optics and advanced non-mydriatic fundus cameras that deliver superior image quality with user-friendly operation. Its strong focus on compact and portable designs makes it a preferred choice in primary care and teleophthalmology.

• TOPCON

Topcon’s USP lies in its wide product range, including hybrid fundus-OCT systems, which streamline workflows by offering comprehensive retinal imaging in a single platform. Its strong global presence and emphasis on AI-driven diagnostic tools further strengthen its market leadership.
 

Fundus Cameras Industry News:

• In June 2025, Optomed announced the launch of Optomed Lumo, a next-generation handheld fundus camera. It delivered enhanced usability, accessibility, and adaptability, enabling retinal health detection in any setting. This development is expected to support the market by promoting portable, user-friendly solutions and expanding adoption in primary care and remote areas.
   
• In May 2024, Optomed, Inc. announced the launch of the Optomed Aurora AEYE, a portable AI fundus camera capable of detecting more than mild diabetic retinopathy. It enabled rapid on-site screening in primary care, reducing delays in diagnosis and referrals. This strengthened the fundus cameras market by promoting AI-driven accessibility and early disease detection.
   
• In March 2022, Epipole announced the global launch of its new epiCam fundus camera in the U.S. eye care industry. The ultra-portable, wireless device used Epipole's video direct ophthalmoscopy (VDO) platform to capture live, high-resolution retinal videos along with still images. This innovation boosted the market by enhancing portability, real-time imaging capabilities, and accessibility in diverse clinical settings.
   

The fundus cameras market research report includes an in-depth coverage of the industry with estimates and forecast in terms of revenue (USD Million) and volume (Units) from 2021 - 2034 for the following segments:

Click here to Buy Section of this Report

Market, By Product

• Mydriatic fundus cameras
  • Tabletop
  • Handheld 
• Non-mydriatic fundus cameras
  • Tabletop
  • Handheld
• Hybrid fundus cameras

Market, By End Use

• Ophthalmology clinics
• Hospitals
• Other end use

The above information is provided for the following regions and countries:

• North America
  • U.S.
  • Canada 
• Europe
  • Germany
  • UK
  • France
  • Spain
  • Italy
  • Netherlands
  • Poland
  • Sweden
• Asia Pacific
  • China
  • Japan
  • India
  • Australia
  • South Korea
  • Indonesia
  • Philippines
  • Vietnam
• Latin America
  • Brazil
  • Mexico
  • Argentina
  • Colombia
  • Chile
  • Peru
• Middle East and Africa
  • South Africa
  • Saudi Arabia
  • UAE
  • Turkey
  • Israel
  • Iran